Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review
- PMID: 34250287
- PMCID: PMC8239370
- DOI: 10.35772/ghm.2021.01076
Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review
Abstract
COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of COVID-19 vaccination on the management of patients scheduled for FDG-PET/CT in the setting of nationwide mass vaccination.
Keywords: COVID-19; FDG; PET/CT; vaccine.
2021, National Center for Global Health and Medicine.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


References
-
- JOHNS HOPKINS CORONAVIRUS RESOURCE CENTER. https://coronavirus.jhu.edu/map.html (last updated at 6/10/2021). (accessed June 21, 2021).
-
- Le TT, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov; 2020: 19:305-306. - PubMed
Publication types
LinkOut - more resources
Full Text Sources